[1]
P. Devabhaktuni, M. Ponnuru, C. L. Devang, and P. V. Rao, “Glycosylated fibronectin positivity in the spectrum of hypertensive disorders of pregnancy in relation to the severity and adverse outcomes”, Int J Reprod Contracept Obstet Gynecol, vol. 11, no. 3, pp. 892–903, Feb. 2022.